Literature DB >> 15090767

Healthcare use by varied highly active antiretroviral therapy (HAART) strata: HAART use, discontinuation, and naivety.

Herminia Palacio1, Xiuhong Li, Tracey E Wilson, Henry Sacks, Mardge H Cohen, Jean Richardson, Mary Young, Alvaro Muñoz.   

Abstract

OBJECTIVES: Prior reports have found a temporal association between the introduction of highly active antiretroviral therapy (HAART) and population rates of health service use among persons living with HIV. Our objective was to explore further the effect of HAART by comparing healthcare use among persons who use HAART and persons who discontinue HAART to that among HAART-naive and HIV-negative persons.
METHODS: Longitudinal analyses of 1485 women with and at-risk for HIV who contributed data to the Women's Interagency HIV Study between April 1997 and March 2000.
RESULTS: Compared with HAART-naive women, those using HAART had a higher probability of more than three primary care visits per 6 months [odds ratio (OR), 1.38; 95% confidence interval (CI), 1.16-1.65), a lower probability of more than one emergency room visit per 6 months (OR, 0.75; CI, 0.59-0.95), and a lower probability of more than one hospitalization per 6 months (OR, 0.67; CI, 0.51-0.88). Compared with HAART-naive women, women who had discontinued HAART had a higher frequency of primary care visits (OR, 1.57; CI, 1.26-1.97) but did not demonstrate a significant change in emergency room or hospital use. Modeling of a standardized population HIV-positive women without AIDS indicated hospitalization and emergency room use among HAART users was equivalent to that among HIV-negative women.
CONCLUSIONS: HIV-positive HAART users (without AIDS) exhibited emergency room and hospitalization use patterns equivalent to those of HIV-negative women. Furthermore, the discontinuation of HAART was associated with a loss of the reduction in hospital use that was achieved with HAART.

Entities:  

Mesh:

Year:  2004        PMID: 15090767     DOI: 10.1097/00002030-200403050-00006

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  8 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 2.  The population effectiveness of highly active antiretroviral therapy: are good drugs good enough?

Authors:  Thomas P Giordano; Maria E Suarez-Almazor; Richard M Grimes
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

3.  Perinatal depressive symptoms in HIV-infected versus HIV-uninfected women: a prospective study from preconception to postpartum.

Authors:  Leah H Rubin; Judith A Cook; Dennis D Grey; Kathleen Weber; Christina Wells; Elizabeth T Golub; Rodney L Wright; Rebecca M Schwartz; Lakshmi Goparaju; Deborah Cohan; Melissa L Wilson; Pauline M Maki
Journal:  J Womens Health (Larchmt)       Date:  2011-07-06       Impact factor: 2.681

4.  Multi-dimensional risk factor patterns associated with non-use of highly active antiretroviral therapy among human immunodeficiency virus-infected women.

Authors:  Alison Snow Jones; Marsha Lillie-Blanton; Valerie E Stone; Edward H Ip; Qiang Zhang; Tracey E Wilson; Mardge H Cohen; Elizabeth T Golub; Nancy A Hessol
Journal:  Womens Health Issues       Date:  2010-06-25

5.  Cervical cytology and histopathologic abnormalities in women living with AIDS in São Paulo, Brazil.

Authors:  Valdir Monteiro Pinto; Jonathan E Golub; Mariza Vono Tancredi; Rosa Souza Alencar; Angelica Espinosa Miranda
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08       Impact factor: 3.731

6.  Emergency department utilization among HIV-infected patients in a multisite multistate study.

Authors:  J S Josephs; J A Fleishman; P T Korthuis; R D Moore; K A Gebo
Journal:  HIV Med       Date:  2009-08-13       Impact factor: 3.180

7.  Which health care facilities do adult Malawian antiretroviral therapy patients utilize during intercurrent illness?A cross sectional study.

Authors:  Caroline Masangalawe; Akuzike Kandulu; Joep J van Oosterhout
Journal:  BMC Health Serv Res       Date:  2011-12-21       Impact factor: 2.655

8.  Healthcare utilization of patients accessing an African national treatment program.

Authors:  Guy Harling; Catherine Orrell; Robin Wood
Journal:  BMC Health Serv Res       Date:  2007-06-07       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.